Corden Pharmachem provides development and manufacturing services for active pharmaceutical ingredients (APIs). We operate two traditional API sites in Europe that have a long history of project development and global regulatory compliance. We have filed over 78 DMFs in 28 countries including the USA. We support initial manufacture of drug substance (NCEs) for clinical trials through to full commercial scale manufacture, multi-tons if needed. We produce and handle controlled substances. Beyond on site chemistry we provide solutions to build complex molecules by utilizing technologies within the ICIG group (ic-investors.com). These include chiral building blocks, pyridine derivatives, hard to produce products from continuous flow micro-reactors, full scale bromination and chlorination and other chemistries for raw materials. At Corden Pharmachem our aim is to improve your chemistry and deliver the best possible value. In the USA contact Jeff Slocum at jeffrey.slocum@cordenpharmachem.com, ph 201 312 5956. In Europe contact eike.hoppmann@cordenpharmachem.com, ph 49 621 765 4349